Bioelectronics Corp (BIEL)

[3331]

Posted at BB's Stock Haven:
Bioelectronics (BIEL) ready for blast-off!
1) Golden Cross and Blue Skies Breakout Imminent! The 50 dma is .0001, 200 dma is .0002, yearly high is .0005.
2) Profitabity: BIEL has cut costs to the bone, such that about $1.5 million annual revenue should make them profitable - they are close, if not already there.
3) pps = .01 possible when revs = $1 mil quarter ($4 mil annually, using hyper growth PE = 100).
4) BIEL's Actipatch/RecoveryRx pain relief medical device sells on Amazon and has numerous international distributors.
5) Actipatch/RecoveryRx is highly effective (often 5 star rated) and should be a Standard of Care for every adult and pet on the planet.
6) They have 5 FDA clearances and a huge new utility patent (pending) for chronic inflammation.
7) Insurance coverage is expanding (currently covered by the UK National Health Service) and potentially in the U.S. with the advent of the NOPAIN Act commencing January 1, 2025.
8) 911 Market Maker signal recently.
9) #1 on the Breakout Boards recently (and #8 on Most Read Boards with over 220,000 reads).
10) Publication of fantastic results for recent clinical studies (for canine and phantom limb pain).